Andreas Pfenning discusses the techniques being developed and used to study neuronal heterogeneity and the therapeutic potential of his work.

BRKR faces macro and currency headwinds, but strong BSI Nano growth, AI-driven demand and BioSpin innovations support its long-term outlook.

The South Korean spatial biology company unveils new AI agents, foundation models, and spatial biomarkers for oncology drug ...

A wave of spatial transcriptomics studies has produced gene-expression atlases that span entire organs and whole organisms, ...

Bioptimus, a global AI company building the world's first world model for biology, today announced the launch of its Spatial Tissue Embedding Learning Atlas (STELA), a multinational spatial data ...

Tumors contain many different types of cells organized in complex spatial patterns that can influence how the disease progresses. Because of this, it is hard to predict how a tumor will develop and ...

Mount Sinai researchers have published the first organ-wide human skin spatial atlas from across the body. It provides an ...

Foundation models (FMs), which are deep learning models pretrained on large-scale data and applied to diverse downstream ...

Chang leads assay and applications development at Takara Bio, driving the commercialization of novel spatial genomics products. She has extensive experience in single-cell multiomics technologies and ...

Jasmine Plummer shares the spatial omics techniques she has developed to investigate the cellular processes underlying ...